A. Dal Pra

N. Dogan, A. Pollack, K. Padgett, 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries

P. Boutros, P. Tran, N. Corcoran, 2020, World Journal of Urology.

Radiation Therapy Versus Radical Prostatectomy: A Never-ending Discussion.

B. Tombal, M. Spahn, D. Aebersold, 2016, European urology.

Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature.

R. Miralbell, A. Dal Pra, T. Zilli, 2016, Cancer treatment reviews.

Erring Characteristics of Deformable Image Registration-Based Auto-Propagation for Internal Target Volume in Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer

L. Young, A. Dal Pra, B. Rich, 2022, Frontiers in Oncology.

Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.

S. Hoffe, E. Mellon, A. Dal Pra, 2020, The British journal of radiology.

Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.

M. Caversaccio, D. Aebersold, A. Dal Pra, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Using hormone therapy with salvage radiotherapy according to presalvage PSA levels

A. Pollack, A. Dal Pra, 2020, Nature Reviews Urology.

Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.043.

A. Dal Pra, T. Zilli, V. Achard, 2020, European urology.

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy

R. Stoyanova, A. Pollack, M. Alhusseini, 2022, Cancers.

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.

A. Kishan, M. Cooperberg, P. Carroll, 2020, European urology.

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer

A. Dal Pra, S. Supiot, T. Zilli, 2017, Front. Oncol..

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic

U. Ricardi, A. Dal Pra, Giuseppe Carlo Iorio, 2020, Frontiers in Oncology.

Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus.

M. Scorsetti, C. Belka, F. Alongi, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer

N. Dogan, A. Pollack, A. Dal Pra, 2022, Radiation Oncology.

Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study

R. Stoyanova, N. Dogan, K. Padgett, 2022, Scientific Reports.

Repeatability of CBCT Radiomic Features and Their Correlation to CT Radiomic Features for Prostate Cancer.

R. Stoyanova, N. Dogan, A. Pollack, 2021, Medical physics.

Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy

E. Bossart, N. Dogan, A. Pollack, 2021, International journal of particle therapy.

Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response

R. Bristow, B. Wouters, V. Zannella, 2013, Clinical Cancer Research.

TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair

A. Evans, T. H. van der Kwast, J. Srigley, 2013, Clinical Cancer Research.

An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.

A. Berlin, A. Dal Pra, R. Bristow, 2014, The British journal of radiology.

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.

Igor Jurisica, Mark J Dunning, Emilie Lalonde, 2014, The Lancet. Oncology.

Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy

D. Aebersold, A. Dal Pra, Bijaya Malla, 2018, Journal of Translational Medicine.

Prostate cancer radiation therapy: A physician's perspective.

A. Dal Pra, L. Souhami, 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

B. Trock, R. Mehra, S. Freedland, 2020, Prostate Cancer and Prostatic Diseases.

Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer.

R. Bristow, A. Dal Pra, Daria Taiakina, 2014, Advances in experimental medicine and biology.

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer

R. Bristow, J. Locke, A. Dal Pra, 2016, Front. Oncol..

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation

D. Aebersold, A. Dal Pra, O. Eliçin, 2018, Radiation oncology.

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.

R. Bristow, A. Berlin, A. Dal Pra, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy

D. Engeler, C. Panje, A. Dal Pra, 2017, Strahlentherapie und Onkologie.

Locally advanced prostate cancer: current controversies and optimisation opportunities.

C. Catton, A. Dal Pra, S. Sridharan, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure

D. Aebersold, P. Ghadjar, A. Dal Pra, 2015, Radiation Oncology.

Clinicogenomic characterization of prostate cancer liver metastases

A. Kishan, R. Dess, B. Mahal, 2022, Prostate Cancer and Prostatic Diseases.

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy

Nesrin Dogan, Radka Stoyanova, John C. Ford, 2018, Translational andrology and urology.

Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database

B. Jeremic, N. Cihoric, D. Aebersold, 2016, Radiation oncology.

Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy

M. Caversaccio, D. Aebersold, A. Dal Pra, 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage III lung cancer

A. Dal Pra, D. Berton, Ricardo F. Silva, 2020, Thoracic cancer.

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure

D. Aebersold, P. Ghadjar, A. Dal Pra, 2015, Radiation oncology.

Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

F. Alongi, B. De Bari, F. Giammarile, 2016, The British journal of radiology.

Urethral strictures after radiation therapy for prostate cancer

M. Spahn, F. Moltzahn, G. Thalmann, 2016, Investigative and clinical urology.

Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland

C. Panje, A. Dal Pra, F. Herrera, 2015, Strahlentherapie und Onkologie.

Contemporary role of postoperative radiotherapy for prostate cancer

R. Stoyanova, A. Pollack, A. Dal Pra, 2018, Translational andrology and urology.

Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University experience.

François DeBlois, Rolina Al-Wassia, Horacio Patrocinio, 2011, International journal of radiation oncology, biology, physics.

Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone.

C. Freeman, A. Dal Pra, L. Souhami, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer.

H. Patrocinio, A. Dal Pra, A. Velly, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg?

M. Fix, P. Manser, D. Aebersold, 2017, Radiation Oncology.

Stereotactic Body Radiotherapy for Localized Kidney Cancer

A. Dal Pra, B. Rich, Miguel Angel Noy, 2022, Current Urology Reports.

Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer.

N. Dogan, A. Pollack, K. Padgett, 2021, Physica medica (Testo stampato).

Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy

D. Aebersold, A. Dal Pra, Bijaya Malla, 2018, Journal of Translational Medicine.

Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.

P. Wust, J. Bernhard, G. Hildebrandt, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

V. Khoo, T. Wiegel, V. Fonteyne, 2023, Clinical and translational radiation oncology.

Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.

E. Bossart, U. Ricardi, A. Dal Pra, 2023, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice

W. Arnold, C. Panje, A. Dal Pra, 2019, Radiation Oncology.

Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspectives based on international consensus.

Xiao Zhi Qiu, J. Epstein, T. Wiegel, 2022, International journal of radiation oncology, biology, physics.

Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma

R. Cameron, M. Ballo, R. Kotecha, 2023, Current oncology.

Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy.

E. Vassella, D. Aebersold, A. Dal Pra, 2017, International journal of radiation oncology, biology, physics.

Does transperitoneal minimally invasive radical prostatectomy increase the amount of small bowel receiving salvage radiation?

W. Kassouf, A. Aprikian, A. Dal Pra, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy

V. Fonteyne, C. Cozzarini, P. Ghadjar, 2023, Clinical and translational radiation oncology.

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation

D. Aebersold, A. Dal Pra, O. Eliçin, 2018, Radiation Oncology.

Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making.

A. Berlin, M. Chua, A. Dal Pra, 2023, International journal of radiation oncology, biology, physics.

Prognostic utility of cell cycle progession score in men with prostate cancer after primary external beam radiation therapy. In regard to Freedland et al.

T. H. van der Kwast, R. Bristow, C. Catton, 2014, International journal of radiation oncology, biology, physics.